- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03669003
Gelfoam to Prevent Pneumothorax After Lung Biopsy
Gelfoam Slurry as an Embolization Agent of the Needle Tract to Prevent Pneumothorax From Percutaneous CT-guided Lung Biopsy: A Randomized Controlled Trial
Lung cancer is the deadliest of all cancers, and its incidence is on the rise. The importance of accurate and efficient lung biopsy without complications will only increase in importance going forward. Pneumothorax is a common complication of CT-guided lung biopsy. The purpose of this study is to assess the efficacy of using Gelfoam slurry in preventing pneumothorax from lung biopsy in a randomized controlled trial. Gelfoam (Pfizer, New York, NY, USA) is gelatin product approved by the Food and Drug Administration (FDA) for hemostasis during various procedures.
In the study group, the needle track will be laced with Gelfoam slurry following biopsy, and will be compared to standard lung biopsy without any other interventions. Both groups will be followed up with chest x-ray for pneumothorax.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
CT-guided percutaneous lung biopsy is an invaluable tool used for the diagnosis of lung cancer. Pneumothorax (PTX) is the most frequent complication of CT-guided percutaneous lung biopsy, with a reported incidence of 9 to 40% and a cumulative average incidence of about 20%. Most of these are managed conservatively and about 7 to 21% will require placement of a chest tube. Several techniques have been used in the past to prevent the development of PTX by sealing the needle tract with various materials (autologous blood, saline, hydrogel, collagen plugs), but literature has shown them to be unreliable, clumsy or costly.
The use of Gelfoam slurry for embolizing the needle tract following biopsy has been identified in a retrospective study as a possible intervention to reduce the occurrence of pneumothorax and/or chest tube placement. Gelfoam (Pfizer, New York, NY, USA) is a gelatin sponge made from bovine corium, which can absorb fluids 40 times its weight and can enlarge by 200% in size. This property allows the material to effectively plug the biopsy track by volumetric expansion, which prevents passage of air from the lung into the pleural cavity and creation of a pneumothorax. Gelfoam is cheap, is readily available both as a sponge and powder and can be easily made into a slurry by mixing with saline. The slurry is semisolid in consistency and can be easily injected through the biopsy cannula into the needle track.
In the experimental group, as the biopsy cannula is withdrawn, Gelfoam will be injected carefully, lacing the needle track. In both groups, immediate post-procedure CT scans and subsequent follow up X-rays 1 and 2 hours post-procedure will be used to monitor for pneumothorax.
Study Type
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami
-
Miami, Florida, United States, 33136
- Jackson Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
To be included in the study, the patient must:
- Be between the ages of 18-80.
- Be indicated for CT-guided percutaneous lung biopsy for evaluation of a solitary pulmonary nodule, or other indicated pulmonary lesion(s).
- Be cooperative.
To be included in the study, the patient must NOT:
- Have known allergy to porcine collagen (basis of Gelfoam).
- Have bleeding diatheses defined by the following coagulation indices: International normalized ratio [INR]>1.5 /platelets<50,000/µL.
- Have had previous pneumonectomy (unless the lesion is pleurally based and accessible without traversing lung tissue.
- Have suspected hyatid cyst (due to risk of anaphylactic reaction).
- Have possible pulmonary arteriovenous malformation (AVM), vascular aneurysm, or pulmonary sequestration (intralobar or extralobar).
- Have a diagnosis of pulmonary hypertension (especially when considering biopsy of a central lesion).
- Require positive pressure ventilation.
- Require consent of proxy to participate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Gelfoam
Gelfoam slurry will be injected at the end of the biopsy procedure.
|
Approximately 1-2cc of Gelfoam slurry will be used to lace the needle track.
|
Active Comparator: Standard procedure
Standard procedure of lung biopsy
|
Biopsy of a lung nodule under CT guidance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in incidence of pneumothorax
Time Frame: 2 hours post-procedure
|
Comparison of the incidence of pneumothorax in participants of standard lung biopsy vs with Gelfoam slurry
|
2 hours post-procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in the rate of necessity for chest tube placement post lung biopsy
Time Frame: 2 hours post-procedure
|
Comparison of the necessity for chest tube placement in participants of standard lung biopsy vs with Gelfoam slurry
|
2 hours post-procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20170830
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumothorax Iatrogenic Postprocedural
-
Centre Hospitalier Universitaire de BesanconInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingPneumothorax Iatrogenic PostproceduralFrance, Ireland
-
Amsterdam UMC, location VUmcGroene Hart ZiekenhuisCompletedPneumothorax Iatrogenic Postprocedural | Malposition, Central Venous CatheterNetherlands
-
National Taiwan University HospitalCompletedIatrogenic Pneumothorax | Vacuum Bottle Assisted Needle AspirationTaiwan
-
Melbourne HealthEnrolling by invitation
-
Tabriz University of Medical SciencesAJA University of Medical SciencesUnknownPneumothorax, Spontaneous | Pneumothorax Spontaneous Primary | Pneumothorax, Recurrent | Pneumothorax Spontaneous TensionIran, Islamic Republic of
-
University of NottinghamFresenius Medical Care Deutschland GmbHCompletedMyocardial Perfusion | Other Postprocedural Cardiac Functional Disturbances
-
Peking University Third HospitalNot yet recruitingPrimary Spontaneous Pneumothorax
-
Rennes University HospitalRecruiting
-
Dow University of Health SciencesUnknownSecondary PneumothoraxPakistan
-
University Hospital, Strasbourg, FranceRecruiting
Clinical Trials on Gelfoam slurry
-
MallinckrodtTerminated
-
University of Sao PauloCompletedRecurrent Malignant Pleural Effusion.Brazil
-
C. R. BardCompletedAortic Valve Stenosis | Aortic Valve Disorder | Aneurysm of Ascending Aorta | Bicuspid Valve DisorderUnited States
-
The Cleveland ClinicOhio State University Comprehensive Cancer CenterCompletedFamilial Adenomatous PolyposisUnited States
-
University of MalayaUnknownOrthodontic Appliance Complication
-
Ohio State UniversityMedical College of WisconsinCompleted
-
CryoLife, Inc.United States Department of DefenseTerminatedIntraoperative BleedingUnited States
-
Tenaxis Medical, Inc.CompletedVascular DiseaseUnited States
-
Dow University of Health SciencesUnknownSecondary PneumothoraxPakistan
-
Theagenio Cancer HospitalCompletedCost Effectiveness | Safety of Intervention | Efficacy of InterventionGreece